St. Louis, MO, United States of America

Marina Celia

This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Marina Celia

Introduction

Marina Celia is an accomplished inventor based in St. Louis, MO (US). She has made significant contributions to the field of biotechnology, particularly through her innovative work involving TREM2 constructs. Her research has the potential to impact various medical applications.

Latest Patents

Marina Celia holds a patent for "Compositions comprising TREM2 and methods of use thereof." This invention provides TREM2 constructs, which are polynucleotide sequences encoding a polypeptide. The polypeptide includes at least one TREM2 or a fragment thereof, along with a targeting moiety. Additionally, the constructs may comprise a signal peptide and/or a purification moiety. The invention also encompasses isolated polypeptides encoded by TREM2 constructs, vectors containing these constructs, isolated cells with said vectors, and methods of use thereof. She has 1 patent to her name.

Career Highlights

Marina Celia is affiliated with Washington University, where she continues her research and development in the field of biotechnology. Her work is recognized for its innovative approach and potential applications in medical science.

Collaborations

Marina collaborates with notable colleagues, including Marco Colonna and Yarning Wang. Their combined expertise enhances the research and development efforts in their respective fields.

Conclusion

Marina Celia is a pioneering inventor whose work on TREM2 constructs showcases her commitment to advancing biotechnology. Her contributions are poised to make a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…